Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06535607

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic…

eVOLVE-02 study will evaluate the efficacy and safety of volrustomig as monotherapy or in combination with anti-cancer agents in participants with advanced/meta…

United States, Brazil257 participantsStarted 2024-08-22

Treatment: Volrustomig, Cisplatin

Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic…

All recent trials (1 shown)